Drug Shortage Report for APO-GATIFLOXACIN

Last updated on 2023-11-24 History
Report ID 205486
Drug Identification Number 02327260
Brand name APO-GATIFLOXACIN
Common or Proper name GATIFLOXACIN
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) GATIFLOXACIN
Strength(s) 0.3%
Dosage form(s) SOLUTION
Route of administration OPHTHALMIC OPHTHALMIC
Packaging size 5 ML
ATC code S01AE
ATC description ANTIINFECTIVES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2023-09-26
Estimated end date 2023-11-24
Actual end date 2023-11-23
Shortage status Resolved
Updated date 2023-11-24
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2023-11-24 French Compare
v11 2023-11-24 English Compare
v10 2023-11-10 French Compare
v9 2023-11-10 English Compare
v8 2023-10-27 French Compare
v7 2023-10-27 English Compare
v6 2023-10-20 French Compare
v5 2023-10-20 English Compare
v4 2023-10-06 French Compare
v3 2023-10-06 English Compare
v2 2023-09-28 French Compare
v1 2023-09-28 English Compare

Showing 1 to 12 of 12